(Q73478299)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Selective decrease of serum immunoglobulin G1 as marker for early stages of invasive breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

L Kronberger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

W Steinschifter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Weblacher

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

W Estelberger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P M Liebmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H Rabl

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Smola

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S F Lax

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H J Mischinger

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

E Schauenstein

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Schauenstein

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

193-199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11194455%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1006450205698

4 November 2019

exact match

0 references

cites work

A novel method for monitoring high-risk breast cancer with tumor markers: CA 15.3 compared to CEA and TPA

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006450205698

7 January 2021

Labile disulfide bonds and free thiol groups in human IgG. I. Assignment to IgG1 and IgG2 subclasses

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006450205698

7 January 2021

Labile disulfide bonds and free thiol groups in human IgG. II. Characteristic changes in malignant diseases corresponding to shifts of IgG1 and IgG2 subclasses

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006450205698

7 January 2021

Selective decrease in serum immunoglobulin G1. A tissue nonspecific tumor marker detecting early stages of gynecologic malignant disease with high efficiency

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006450205698

7 January 2021

Sigma S, a measure of reactive sulfur groups of immunoglobulin G, is a sensitive tumor marker discriminating different stages of breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006450205698

7 January 2021

The IgG1/G2 subclass shift--a sensitive, tissue non-specific marker for malignancy. Diagnostic performance with squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006450205698

7 January 2021

Selective decrease of serum immunoglobulin G1 as a marker of malignant transformation in colorectal tissue

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006450205698

7 January 2021

Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006450205698

7 January 2021

A decrease in reactive disulfide bonds of serum IgG signals a characteristic change in the IgG subclass patterns of rats bearing experimental tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006450205698

7 January 2021

1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006450205698

7 January 2021

Prospective investigation of tumor markers and risk assessment in early cancer screening

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006450205698

7 January 2021

Clinical Applications of Serum Tumor Markers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006450205698

7 January 2021

The tumor-associated shift in immunoglobulin G1/G2 is expressed at the messenger RNA level of peripheral blood B lymphocytes in patients with gynecologic malignancies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006450205698

7 January 2021